Pharmaceutical Innovation and Pipeline Drugs Highlight Recent Autism Spectrum Disorder Market Research
While behavioral therapy remains the "gold standard" for ASD, the pharmaceutical pipeline is more active than ever. Researchers are moving beyond just treating secondary symptoms like aggression or insomnia and are now investigating the biological underpinnings of social communication deficits. New drug candidates targeting the oxytocin system, the gut-brain axis, and specific neurotransmitters...
0 Commentaires 0 Parts 108 Vue 0 Aperçu